Taleo announces pricing of initial public offering

Taleo announced today the pricing of its initial public offering of 6,700,000 shares of its common stock at $14.00 per share (before underwriting discounts and commissions). Taleo offered 5,360,000 shares of common stock, while the remaining 1,340,000 shares were offered by selling stockholders. The selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 1,005,000 shares of common stock to cover over-allotments, if any.

The offering is expected to close on October 4, 2005. The shares have been approved to trade on the NASDAQ National Market under the symbol "TLEO." 

The shares are being sold through underwriters led by Citigroup Global Markets, Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated, J.P. Morgan Securities Inc., CIBC World Markets Corp. and ThinkEquity Partners LLC. Copies of the final prospectus related to the offering can be obtained by contacting Citigroup at: Citigroup Global Markets Inc. at Brooklyn Army Terminal, 140 58th Street, 8th Floor, Brooklyn, NY 11220, USA (Telephone +1-718-765-6732). The prospectus will also be available on the Securities and Exchange Commission website at http://www.sec.gov.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on September 28, 2005, and the public offering is being made by means of a prospectus. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor will there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Note to Editors: Taleo is a registered trademark of Taleo Corporation. Other product or service names mentioned herein remain the property of their respective owners.

About Taleo
Taleo (NASDAQ: TLEO) delivers on demand talent management solutions that enable organisations of all sizes to recruit, assess and manage their workforces for improved business performance. Taleo’s customers use its suite of solutions to improve their talent management processes to reduce the time and costs associated with these processes and to enhance the quality, productivity and satisfaction of their workforces. Taleo currently has more than 300 corporate customers with approximately 475,000 registered users who use our services to fill positions in almost 100 countries.

Cautionary Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements represent Taleo Corporation’s current expectations and beliefs, including its intent and ability to complete the proposed public offering described above. The forward-looking statements, however, are subject to certain risks and uncertainties that could cause the actual results, performance or achievements to be materially different from those expressed, expected or implied by the forward-looking statements. These risks and uncertainties are described in Taleo Corporation’s filings with the Securities and Exchange Commission. Taleo Corporation does not undertake to update forward-looking information contained herein or elsewhere to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information. You should not rely upon forward-looking statements as predictions of future events. We cannot assure you that the events and circumstances reflected in the forward-looking statements will be achieved or occur, nor do we undertake any obligation to update any forward-looking statements for any reason after the date of this press release.

Media Contact:
Christine Ducos
+33 6 32 46 01 48

Investor Relations Contact:
Kori Doherty
Integrated Corporate
+1 617 217 2084

Issuers of news releases, not Targetwire, are solely responsible for the accuracy of the content.